Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid Tumors
Clinical trial NCT03588039 · TERMINATED
Trial details
- NCT number
- NCT03588039
- Sponsor
- Athenex, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-25
- Primary completion
- 2023-05-12
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.